Coupled transcription-splicing regulation of mutually exclusive splicing events at the 5′ exons of protein 4.1R gene

Blood

Volumn 114, Issue 19, 2009, Pages 4233-4242

  Huang, Shu Ching ^a,b   Cho, Aeri ^a   Norton, Stephanie ^a   Liu, Eva S ^a   Park, Jennie ^a   Zhou, Anyu ^a,b   Munagala, Indira D ^a   Ou, Alexander C ^a   Yang, Guang ^a,b   Wickrema, Amittha ^c   Tang, Tang K ^d   Benz Jr , Edward J ^a,b,e,f,g  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^e DANA FARBER HARVARD CANCER CENTER   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROCYTE BAND 4.1 PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ERYTHROLEUKEMIA CELL; ERYTHROPOIESIS; EXON; GENE EXPRESSION REGULATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; RNA SPLICING;

EID: 77950539535     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-02-206219     Document Type: Article

References (49)

1. Bentley D. Coupling RNA polymerase II transcription with pre-mRNA processing. Curr Opin Cell Biol. 1999;11(3):347-351.
2. Hirose Y, Manley JL. RNA polymerase II and the integration of nuclear events. Genes Dev. 2000;14(12):1415-1429.
3. Proudfoot N. Connecting transcription to messenger RNA processing. Trends Biochem Sci. 2000;25(6):290-293.
4. Maniatis T, Reed R. An extensive network of coupling among gene expression machines. Nature. 2002;416(6880):499-506.
5. Toki T, Arai K, Terui K, et al. Functional characterization of the two alternative promoters of human p45 NF-E2 gene. Exp Hematol. 2000;28(10):1113- 1119.
6. Tan JS, Mohandas N, Conboy JG. High frequency of alternative first exons in erythroid genes suggests a critical role in regulating gene function. Blood. 2006;107(6):2557-2561.
7. Landry JR, Mager DL, Wilhelm BT. Complex controls: the role of alternative promoters in mammalian genomes. Trends Genet. 2003;19(10):640-648.
8. Kogerman P, Krause D, Rahnama F, et al. Alternative first exons of PTCH1 are differentially regulated in vivo and may confer different functions to the PTCH1 protein. Oncogene. 2002;21(39):6007-6016.
9. Nozell S, Chen X. p21B, a variant of p21(Waf1/Cip1), is induced by the p53 family. Oncogene. 2002;21(8):1285-1294.
10. Parra MK, Gee SL, Koury MJ, Mohandas N, Conboy JG. Alternative 5′ exons and differential splicing regulate expression of protein 4.1R isoforms with distinct N-termini. Blood. 2003;101(10):4164-4171.
11. Kornblihtt AR. Promoter usage and alternative splicing. Curr Opin Cell Biol. 2005;17(3):262-268.
12. Meshorer E, Toiber D, Zurel D, et al. Combinatorial complexity of 5′ alternative acetylcholinesterase transcripts and protein products. J Biol Chem. 2004;279(28):29740-29751.
13. Pfeifer I, Anderson C, Werner R, Oltra E. Redefining the structure of the mouse connexin43 gene: selective promoter usage and alternative splicing mechanisms yield transcripts with different translational efficiencies. Nucleic Acids Res. 2004;32(15):4550-4562.
14. Pecci A, Viegas LR, Baranao JL, Beato M. Promoter choice influences alternative splicing and determines the balance of isoforms expressed from the mouse bcl-X gene. J Biol Chem. 2001;276(24):21062-21069.
15. Cramer P, Caceres JF, Cazalla D, et al. Coupling of transcription with alternative splicing: RNA pol II promoters modulate SF2/ASF and 9G8 effects on an exonic splicing enhancer. Mol Cell. 1999;4(2):251-258.
16. de la Mata M, Kornblihtt AR. RNA polymerase II C-terminal domain mediates regulation of alternative splicing by SRp20. Nat Struct Mol Biol. 2006;13(11):973-980.
17. Nogués G, Kadener S, Cramer P, et al. Control of alternative pre-mRNA splicing by RNA Pol II elongation: faster is not always better. IUBMB Life. 2003;55(4-5):235-241.
18. Nogués G, Munoz MJ, Kornblihtt AR. Influence of polymerase II processivity on alternative splicing depends on splice site strength. J Biol Chem. 2003;278(52):52166-52171.
19. Tang TK, Qin Z, Leto T, Marchesi VT, Benz EJ Jr. Heterogeneity of mRNA and protein products arising from the protein 4.1 gene in erythroid and nonerythroid tissues. J Cell Biol. 1990;110(3):617-624.
20. Conboy JG, Chan J, Mohandas N, Kan YW. Multiple protein 4.1 isoforms produced by alternative splicing in human erythroid cells. Proc Natl Acad Sci U S A. 1988;85(23):9062-9065.
21. Baklouti F, Huang SC, Tang TK, Delaunay J, Marchesi VT, Benz EJ Jr. Asynchronous regulation of splicing events within protein 4.1 premRNA during erythroid differentiation. Blood. 1996;87(9):3934-3941.
22. Chasis JA, Coulombel L, Conboy J, et al. Differentiation-associated switches in protein 4.1 expression. Synthesis of multiple structural isoforms during normal human erythropoiesis. J Clin Invest. 1993;91(1):329-338.
23. Deguillien M, Huang SC, Moriniere M, Dreumont N, Benz EJ Jr, Baklouti F. Multiple cis elements regulate an alternative splicing event at 4.1R premRNA during erythroid differentiation. Blood. 2001;98(13):3809-3816.
24. Hou VC, Lersch R, Gee SL, et al. Decrease in hnRNP A/B expression during erythropoiesis mediates a pre-mRNA splicing switch. EMBO J. 2002;21(22):6195- 6204.
25. Ponthier JL, Schluepen C, Chen W, et al. Fox-2 splicing factor binds to a conserved intron motif to promote inclusion of protein 4.1R alternative exon 16. J Biol Chem. 2006;281(18):12468-12474.
26. Yang G, Huang SC, Wu JY, Benz EJ Jr. An erythroid differentiation- specific splicing switch in protein 4.1R mediated by the interaction of SF2/ASF with an exonic splicing enhancer. Blood. 2005;105(5):2146-2153.
27. Yang G, Huang SC, Wu JY, Benz EJ Jr. Regulated Fox-2 isoform expression mediates protein 4.1R splicing during erythroid differentiation. Blood. 2008;111(1):392-401.
28. 65 RS region with pre-mRNA branch point and promotion of base pairing with U2 snRNA [corrected]. Science. 1996;273(5282):1706-1709.
29. 35. Nature. 1999;402(6763):832-835.
30. 35 and the 3′ splice site AG. Nature. 1999;402(6763):838-841.
31. Patel VP, Lodish HF. A fibronectin matrix is required for differentiation of murine erythroleukemia cells into reticulocytes. J Cell Biol. 1987;105(6 Pt 2):3105-3118.
32. Blobel GA, Nakajima T, Eckner R, Montminy M, Orkin SH. CREB-binding protein cooperates with transcription factor GATA-1 and is required for erythroid differentiation. Proc Natl Acad Sci U SA. 1998;95(5):2061-2066.
33. Paddison PJ, Cleary M, Silva JM, et al. Cloning of short hairpin RNAs for gene knockdown in mammalian cells. Nat Methods. 2004;1(2):163-167.
34. Mahmud DL, G-Amlak M, Deb DK, Platanias LC, Uddin S, Wickrema A. Phosphorylation of forkhead transcription factors by erythropoietin and stem cell factor prevents acetylation and their interaction with coactivator p300 in erythroid progenitor cells. Oncogene. 2002;21(10):1556-1562.
35. Giarratana MC, Kobari L, Lapillonne H, et al. Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells. Nat Biotechnol. 2005;23(1):69-74.
36. Listerman I, Sapra AK, Neugebauer KM. Cotranscriptional coupling of splicing factor recruitment and precursor messenger RNA splicing in mammalian cells. Nat Struct Mol Biol. 2006;13(9):815-822.
37. Dignam JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983;11(5):1475-1489.
38. Santos-Rosa H, Schneider R, Bannister AJ, et al. Active genes are tri-methylated at K4 of histone H3. Nature. 2002;419(6905):407-411.
39. Misteli T, Caceres JF, Spector DL. The dynamics of a pre-mRNA splicing factor in living cells. Nature. 1997;387(6632):523-527.
40. Graveley BR, Maniatis T. Arginine/serine-rich domains of SR proteins can function as activators of pre-mRNA splicing. Mol Cell. 1998;1(5):765-771.
41. Pérez-Ferreiro CM, Vernos I, Correas I. Protein 4.1R regulates interphase microtubule organization at the centrosome. J Cell Sci. 2004;117(Pt 25):6197-6206.
42. Krauss SW, Chen C, Penman S, Heald R. Nuclear actin and protein 4.1: essential interactions during nuclear assembly in vitro. Proc Natl Acad Sci U S A. 2003;100(19):10752-10757.
43. Smith CL, Hager GL. Transcriptional regulation of mammalian genes in vivo. A tale of two templates. J Biol Chem. 1997;272(44):27493-27496.
44. Parra MK, Tan JS, Mohandas N, Conboy JG. Intrasplicing coordinates alternative first exons with alternative splicing in the protein 4.1R gene. EMBO J. 2008;27(1):122-131.
45. Das R, Yu J, Zhang Z, et al. SR proteins function in coupling RNAP II transcription to pre-mRNA splicing. Mol Cell. 2007;26(6):867-881.
46. Phatnani HP, Greenleaf AL. Phosphorylation and functions of the RNA polymerase II CTD. Genes Dev. 2006;20(21):2922-2936.
47. Buratowski S. The CTD code. Nat Struct Biol. 2003;10(9):679-680.
48. Bird G, Zorio DA, Bentley DL. RNA polymerase II carboxy-terminal domain phosphorylation is required for cotranscriptional pre-mRNA splicing and 3′-end formation. Mol Cell Biol. 2004;24(20):8963-8969.
49. Cáceres JF, Kornblihtt AR. Alternative splicing: multiple control mechanisms and involvement in human disease. Trends Genet. 2002;18(4):186-193.